KEGG   PATHWAY: csab05213
Entry
csab05213                   Pathway                                
Name
Endometrial cancer - Chlorocebus sabaeus (green monkey)
Description
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Class
Human Diseases; Cancer: specific types
Pathway map
csab05213  Endometrial cancer
csab05213

Organism
Chlorocebus sabaeus (green monkey) [GN:csab]
Gene
103236114  EGF; epidermal growth factor [KO:K04357]
103226055  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
103221212  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
103241599  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
103225637  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
103234391  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
103224900  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
103222594  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
103216211  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
103247598  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
103241301  ILK; integrin linked kinase [KO:K06272] [EC:2.7.11.1]
103234702  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
103230869  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
103229784  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
103225550  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]
103233293  BAD; BCL2 associated agonist of cell death [KO:K02158]
103240621  FOXO3; forkhead box O3 [KO:K09408]
103243048  GRB2; growth factor receptor bound protein 2 [KO:K04364]
103228953  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
103220440  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
103246363  HRAS; HRas proto-oncogene, GTPase [KO:K02833]
103218763  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]
103224167  NRAS; neuroblastoma RAS viral oncogene homolog [KO:K07828]
103231895  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]
103227022  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]
103228031  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
103245451  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
103233717  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
103222941  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
103230532  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
103231899  ELK1; ELK1, ETS transcription factor [KO:K04375]
103221085  MLH1; mutL homolog 1 [KO:K08734]
103233229  CDH1; cadherin 1 [KO:K05689]
103227444  CTNNB1; catenin beta 1 [KO:K02105]
103216111  CTNNA3; catenin alpha 3 [KO:K05691]
103219983  CTNNA2; catenin alpha 2 [KO:K05691]
103244602  CTNNA1; catenin alpha 1 [KO:K05691]
103225216  AXIN1; axin 1 [KO:K02157]
103243176  AXIN2; axin 2 [KO:K04385]
103234321  APC2; APC2, WNT signaling pathway regulator [KO:K02085]
103244338  APC; APC, WNT signaling pathway regulator [KO:K02085]
103228213  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
103244543  TCF7; transcription factor 7 (T-cell specific, HMG-box) [KO:K02620]
103219950  TCF7L1; transcription factor 7 like 1 [KO:K04490]
103216817  TCF7L2; transcription factor 7 like 2 [KO:K04491]
103236088  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]
103237430  MYC; v-myc avian myelocytomatosis viral oncogene homolog [KO:K04377]
103246489  CCND1; cyclin D1 [KO:K04503]
103242323  TP53; tumor protein p53 [KO:K04451]
103221583  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]
103224652  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]
103233650  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]
103219731  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]
103235004  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]
103221651  BAK1; BCL2 antagonist/killer 1 [KO:K14021]
103236219  DDB2; damage specific DNA binding protein 2 [KO:K10140]
103223255  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
103243533  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Related
pathway
csab04010  MAPK signaling pathway
csab04012  ErbB signaling pathway
csab04060  Cytokine-cytokine receptor interaction
csab04110  Cell cycle
csab04115  p53 signaling pathway
csab04151  PI3K-Akt signaling pathway
csab04310  Wnt signaling pathway
csab04520  Adherens junction
KO pathway
ko05213   
LinkDB

DBGET integrated database retrieval system